✨ Free AI Report
Insulet Corporation: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Insulet Corporation
Company Research

Insulet Corporation: Business Overview, Financials & Competitive Analysis

Insulet Corporation scores 9/10 on the AskCyborg Cyborg Score (Exceptional). Insulet is a high-growth medtech leader with dominant market position, expanding margins, and multiple growth vectors in a $30B+ TAM with significant international and Type 2 expansion opportunities. Insulet offers a rare combination of 20%+ revenue growth, expanding margins, and a dominant market position in a sector with high barriers.

What is Insulet Corporation's industry? Insulet Corporation (insulet.com) operates in Medical Devices - Insulin Delivery Systems / Automated Insulin Delivery (AID). AskCyborg classifies Insulet Corporation under Medical Devices - Insulin Delivery Systems / Automated Insulin Delivery (AID) in its company registry.

Insulet Corporation is the global leader in tubeless insulin pump technology with its Omnipod brand of products. Once pigeonholed as a niche player in the Type 1 diabetes market, the company has transformed into a hig...

9/ 10Exceptional

Cyborg Score thesis

Insulet is a high-growth medtech leader with dominant market position, expanding margins, and multiple growth vectors in a $30B+...

Read the full analyst-debate transcript →
Industry Medical Devices - Insulin Delivery Systems / Automated Insulin Delivery (AID)
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Insulet Corporation Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Insulet Corporation

AskCyborg analysts argue the bull and bear cases for Insulet Corporation across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Insulet Corporation OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Insulet Corporation Overview

Pro stress-test →

Insulet Corporation is the global leader in tubeless insulin pump technology with its Omnipod brand of products. Once pigeonholed as a niche player in the Type 1 diabetes market, the company has transformed into a high-growth med-tech powerhouse with successful integration of its automated insulin delivery (AID) system and massive expansion into the Type 2 diabetes population. Insulet is focused on driving growth within its $30 billion-plus total addressable market.

Strategic Profile

Pro stress-test →

The Omnipod 5 Automated Insulin Delivery System integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections and can be controlled by a compatible personal smartphone in the U.S. By early 2026, the company has successfully debunked the GLP-1 death sentence narrative and proved that its tubeless, pharmacy-distributed model is the most scalable way to manage insulin-dependent diabetes. Adjusted Diluted Earnings Per Share are anticipated to grow at a CAGR of 25%+.

Competitive Landscape

Pro stress-test →

Insulet disrupted the paradigm with the Omnipod as the world's first tubeless, wearable insulin Pod. The company competes in the insulin delivery market against traditional tubed pump systems and multiple daily injection therapy. Key competitors include established medical device companies offering traditional tubed pump systems and newer players in automated insulin delivery.

Industry Context

Insulet Corporation operates in Medical Devices - Insulin Delivery Systems / Automated Insulin Delivery (AID).

Key facts

Founded: 2000 · Headquarters: Acton, Massachusetts · Revenue: $2.07B (2024)

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Insulet Corporation.

  • The expected 2026 launch of a Pod specifically for Type 2 basal users could double the company's daily new patient starts
  • Insulet unveiled enhancements to Omnipod 5 intended to launch in 2026, along with two next-generation systems expected to drive the next phase of the company's growth
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 20262025 financial results announcement scheduled for February 18, 2026
  • January 2026Insulet debuted at CES 2026 showcasing liveable technology vision for connected health
  • +2 moreTrack every material event for Insulet Corporation as it happens. Explore monitoring →
Get alerted when Insulet Corporation has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

ParadigmTubed insulin pump system→t:slimTubed automated insulin delivery system→Multiple Daily InjectionsTraditional insulin delivery method→

Compare Insulet Corporation with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Insulet Corporation operates in Medical Devices - Insulin Delivery Systems / Automated Insulin Delivery (AID). See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices - Insulin Delivery Systems / Automated Insulin Delivery (AID) research →
NEW · MCP server

Ask your AI assistant about Insulet Corporation

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Insulet Corporation and its top competitor on Cyborg Score”
“What did Insulet Corporation do this quarter?”
“Is Insulet Corporation a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Insulet Corporation do?+
Insulet Corporation is the global leader in tubeless insulin pump technology with its Omnipod brand of products. Once pigeonholed as a niche player in the Type 1 diabetes market, the company has transformed into a hig...
What is Insulet Corporation's Cyborg Score?+
Insulet Corporation has a Cyborg Score of 9/10 (Exceptional). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Insulet Corporation's main competitors?+
Named competitors include Paradigm, t:slim, Multiple Daily Injections. The full competitive landscape is in the AskCyborg report.
How can I get the full Insulet Corporation research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Insulet Corporation research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Insulet Corporation over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.